vs

Side-by-side financial comparison of Powerfleet, Inc. (AIOT) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Powerfleet, Inc. is the larger business by last-quarter revenue ($113.5M vs $74.7M, roughly 1.5× Health Catalyst, Inc.). Powerfleet, Inc. runs the higher net margin — -3.0% vs -121.9%, a 118.9% gap on every dollar of revenue. On growth, Powerfleet, Inc. posted the faster year-over-year revenue change (6.6% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $4.9M). Over the past eight quarters, Powerfleet, Inc.'s revenue compounded faster (81.2% CAGR vs -0.0%).

Powerfleet, Inc. is an American company headquartered in Woodcliff Lake, New Jersey, that operates as a global provider of IoT and M2M solutions for securing, controlling, and tracking high-value enterprise assets. The company is a provider in the international telematics industry, providing fleet management, asset tracking, freight visibility, and driver behavior monitoring for industrial trucks, vehicle fleets, and shipping containers.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

AIOT vs HCAT — Head-to-Head

Bigger by revenue
AIOT
AIOT
1.5× larger
AIOT
$113.5M
$74.7M
HCAT
Growing faster (revenue YoY)
AIOT
AIOT
+12.8% gap
AIOT
6.6%
-6.2%
HCAT
Higher net margin
AIOT
AIOT
118.9% more per $
AIOT
-3.0%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$4.7M more FCF
HCAT
$9.6M
$4.9M
AIOT
Faster 2-yr revenue CAGR
AIOT
AIOT
Annualised
AIOT
81.2%
-0.0%
HCAT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AIOT
AIOT
HCAT
HCAT
Revenue
$113.5M
$74.7M
Net Profit
$-3.4M
$-91.0M
Gross Margin
55.2%
Operating Margin
5.6%
-115.3%
Net Margin
-3.0%
-121.9%
Revenue YoY
6.6%
-6.2%
Net Profit YoY
76.6%
-340.3%
EPS (diluted)
$-0.03
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIOT
AIOT
HCAT
HCAT
Q4 25
$113.5M
$74.7M
Q3 25
$111.7M
$76.3M
Q2 25
$104.1M
$80.7M
Q1 25
$103.6M
$79.4M
Q4 24
$106.4M
$79.6M
Q3 24
$77.0M
$76.4M
Q2 24
$75.4M
$75.9M
Q1 24
$74.7M
Net Profit
AIOT
AIOT
HCAT
HCAT
Q4 25
$-3.4M
$-91.0M
Q3 25
$-4.3M
$-22.2M
Q2 25
$-10.2M
$-41.0M
Q1 25
$-12.4M
$-23.7M
Q4 24
$-14.3M
$-20.7M
Q3 24
$-1.9M
$-14.7M
Q2 24
$-22.3M
$-13.5M
Q1 24
$-20.6M
Gross Margin
AIOT
AIOT
HCAT
HCAT
Q4 25
55.2%
Q3 25
56.0%
52.6%
Q2 25
54.2%
Q1 25
52.8%
Q4 24
55.2%
Q3 24
53.7%
47.5%
Q2 24
52.6%
Q1 24
Operating Margin
AIOT
AIOT
HCAT
HCAT
Q4 25
5.6%
-115.3%
Q3 25
3.8%
-22.9%
Q2 25
-2.0%
-46.0%
Q1 25
-6.7%
-25.4%
Q4 24
-1.2%
-22.0%
Q3 24
0.7%
-17.9%
Q2 24
-24.2%
-20.8%
Q1 24
-30.5%
Net Margin
AIOT
AIOT
HCAT
HCAT
Q4 25
-3.0%
-121.9%
Q3 25
-3.8%
-29.1%
Q2 25
-9.8%
-50.8%
Q1 25
-12.0%
-29.9%
Q4 24
-13.5%
-26.0%
Q3 24
-2.5%
-19.3%
Q2 24
-29.6%
-17.8%
Q1 24
-27.6%
EPS (diluted)
AIOT
AIOT
HCAT
HCAT
Q4 25
$-0.03
$-1.29
Q3 25
$-0.03
$-0.32
Q2 25
$-0.08
$-0.59
Q1 25
$-0.09
$-0.35
Q4 24
$-0.11
$-0.33
Q3 24
$-0.02
$-0.24
Q2 24
$-0.21
$-0.23
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIOT
AIOT
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$31.2M
$95.7M
Total DebtLower is stronger
$237.8M
$153.3M
Stockholders' EquityBook value
$485.0M
$245.8M
Total Assets
$959.5M
$502.6M
Debt / EquityLower = less leverage
0.49×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIOT
AIOT
HCAT
HCAT
Q4 25
$31.2M
$95.7M
Q3 25
$27.9M
$91.5M
Q2 25
$31.2M
$97.3M
Q1 25
$44.4M
$342.0M
Q4 24
$33.6M
$392.0M
Q3 24
$26.0M
$387.3M
Q2 24
$30.2M
$308.3M
Q1 24
$327.8M
Total Debt
AIOT
AIOT
HCAT
HCAT
Q4 25
$237.8M
$153.3M
Q3 25
$238.2M
$153.1M
Q2 25
$239.0M
$153.0M
Q1 25
$237.5M
$382.9M
Q4 24
$238.5M
$382.4M
Q3 24
$113.6M
$345.0M
Q2 24
$113.7M
Q1 24
Stockholders' Equity
AIOT
AIOT
HCAT
HCAT
Q4 25
$485.0M
$245.8M
Q3 25
$468.8M
$331.9M
Q2 25
$460.7M
$347.5M
Q1 25
$446.6M
$376.8M
Q4 24
$458.4M
$365.2M
Q3 24
$451.0M
$355.0M
Q2 24
$390.4M
$357.0M
Q1 24
$357.2M
Total Assets
AIOT
AIOT
HCAT
HCAT
Q4 25
$959.5M
$502.6M
Q3 25
$936.9M
$587.1M
Q2 25
$930.8M
$616.2M
Q1 25
$910.1M
$891.5M
Q4 24
$908.7M
$858.9M
Q3 24
$748.3M
$813.0M
Q2 24
$684.9M
$691.7M
Q1 24
$695.1M
Debt / Equity
AIOT
AIOT
HCAT
HCAT
Q4 25
0.49×
0.62×
Q3 25
0.51×
0.46×
Q2 25
0.52×
0.44×
Q1 25
0.53×
1.02×
Q4 24
0.52×
1.05×
Q3 24
0.25×
0.97×
Q2 24
0.29×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIOT
AIOT
HCAT
HCAT
Operating Cash FlowLast quarter
$10.2M
$9.9M
Free Cash FlowOCF − Capex
$4.9M
$9.6M
FCF MarginFCF / Revenue
4.4%
12.9%
Capex IntensityCapex / Revenue
4.6%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$12.9M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIOT
AIOT
HCAT
HCAT
Q4 25
$10.2M
$9.9M
Q3 25
$5.5M
$-464.0K
Q2 25
$4.7M
$-9.0M
Q1 25
$13.5M
$280.0K
Q4 24
$-6.1M
$-3.5M
Q3 24
$-3.2M
$6.2M
Q2 24
$-7.6M
$1.6M
Q1 24
$10.3M
Free Cash Flow
AIOT
AIOT
HCAT
HCAT
Q4 25
$4.9M
$9.6M
Q3 25
$1.2M
$-719.0K
Q2 25
$-3.4M
$-9.2M
Q1 25
$10.1M
$-390.0K
Q4 24
$-12.2M
$-3.9M
Q3 24
$-8.0M
$5.5M
Q2 24
$-13.2M
$1.3M
Q1 24
$10.1M
FCF Margin
AIOT
AIOT
HCAT
HCAT
Q4 25
4.4%
12.9%
Q3 25
1.1%
-0.9%
Q2 25
-3.3%
-11.4%
Q1 25
9.8%
-0.5%
Q4 24
-11.5%
-4.9%
Q3 24
-10.4%
7.2%
Q2 24
-17.5%
1.7%
Q1 24
13.5%
Capex Intensity
AIOT
AIOT
HCAT
HCAT
Q4 25
4.6%
0.4%
Q3 25
3.9%
0.3%
Q2 25
7.8%
0.3%
Q1 25
3.3%
0.8%
Q4 24
5.8%
0.5%
Q3 24
6.3%
0.9%
Q2 24
7.4%
0.4%
Q1 24
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIOT
AIOT

Services$91.1M80%
Products$22.4M20%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons